Japan Health Panel Approves Merck's Oral COVID-19 Treatment
A Japanese health ministry panel recommended approval of the COVID-19 antiviral pill developed by Merck last week, part of plans by Prime Minister Fumio Kishida to roll out new treatments by year's end.
Reuters Health Information
source https://www.medscape.com/viewarticle/965561?src=rss
Reuters Health Information
source https://www.medscape.com/viewarticle/965561?src=rss
Comments
Post a Comment